Related references
Note: Only part of the references are listed.A 5-Decade Analysis of Incidence Trends of Ischemic Stroke After Transient Ischemic Attack A Systematic Review and Meta-analysis
Shima Shahjouei et al.
JAMA NEUROLOGY (2021)
Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Gabriela Trifan et al.
CIRCULATION (2021)
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
S. Claiborne Johnston et al.
STROKE (2021)
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
Dawn O. Kleindorfer et al.
STROKE (2021)
European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA
Jesse Dawson et al.
EUROPEAN STROKE JOURNAL (2021)
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
Liping Liu et al.
STROKE AND VASCULAR NEUROLOGY (2020)
The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design
S. Claiborne Johnston et al.
INTERNATIONAL JOURNAL OF STROKE (2019)
Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke A Secondary Analysis from the POINT Randomized Trial
S. Claiborne Johnston et al.
CIRCULATION (2019)
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials
Yuesong Pan et al.
JAMA NEUROLOGY (2019)
Antiplatelet Therapy after Ischemic Stroke or TIA
James C. Grotta
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack: Compiled by the Chinese Society of Neurology, Cerebrovascular Disease Group
Yongjun Wang et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)
J. Donald Easton et al.
CIRCULATION (2017)
Dual antiplatelet therapy after stroke or transient ischaemic attack - how long to treat? The duration of aspirin plus clopidogrel in stroke or transient ischaemic attack: a systematic review and meta-analysis
F. Ge et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
Pierre Amarenco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease
Peter B. Berger et al.
CIRCULATION (2010)
Platelet function testing and risk of bleeding complications
Jose Luis Ferreiro et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Weighing Benefits and Risks -- The FDA's Review of Prasugrel.
Ellis F. Unger
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke
Nai-Wen Tsai et al.
THROMBOSIS RESEARCH (2009)
Serial changes in platelet activation in patients after ischemic stroke - Role of pharmacodynamic modulation
HK Yip et al.
STROKE (2004)
Share Paper
